Showing results (21-30 of 48) with videos related to
Sort By:
Pageof 5
Mathematical Biosciences|May 1, 1990
How bad can it get? Bounding worst case endemic heterogeneous mixing models of HIV/AIDSE H Kaplan, Y S LeeMedical Decision Making : an International Journal of the Society for Medical Decision Making|October 31, 1997
The cost-effectiveness of HIV testing: accounting for differential participation ratesA D Paltiel, E H KaplanJournal of Acquired Immune Deficiency Syndromes|February 1, 1993
The epidemiological and economic consequences of AIDS clinical trialsA D Paltiel, E H KaplanJournal of Acquired Immune Deficiency Syndromes (1999)|June 3, 2000
Repeat screening for HIV: when to test and whyE H Kaplan, G A SattenMathematical Biosciences|September 3, 1999
Hold everything! Holding policies for protecting plasma suppliesE H Kaplan, G A SattenJournal of Acquired Immune Deficiency Syndromes|January 1, 1991
Modeling zidovudine therapy: a cost-effectiveness analysisA D Paltiel, E H KaplanThe Psychoanalytic Quarterly|January 1, 1975
Evaluation of progress in supervisionS S Weiss, J FlemingJournal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|April 30, 1998
HIV incidence in Ethiopian immigrants to IsraelE H Kaplan, E Kedem, S PollackPublic Health Reports (Washington, D.C. : 1974)|July 1, 1995
'Dropouts' or 'drop-ins'? Client retention and participation in New Haven's needle exchange programK Khoshnood, E H Kaplan, R HeimerPageof 5